SAN DIEGO, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that the U.S. Food and Drug Administration (FDA) approved ...
Despite being the most common vaginal condition,1 BV symptoms are often mistaken for a yeast infection2 JERSEY CITY, N.J.--(BUSINESS WIRE)-- Organon (NYSE: OGN), a global healthcare company with a ...
LAVAL, QC / ACCESS Newswire / July 10, 2025 / Bausch Health (BHC), Canada Inc., part of Bausch Health Companies Inc., today announced that Pr CABTREO TM (clindamycin phosphate, adapalene and benzoyl ...
Treatment with clindamycin vs trimethoprim/sulfamethoxazole was associated with a significantly higher rate of gout flares, particularly among patients with chronic ...
Investing.com -- Glenmark Pharmaceuticals (NSE:GLEN) Inc., USA, has announced the launch of Clindamycin Phosphate Foam, 1%, a ...
Please provide your email address to receive an email when new articles are posted on . 52.7% of pediatric patients treated with the triple-combination gel vs. 24% of vehicle-treated patients achieved ...
Please provide your email address to receive an email when new articles are posted on . The triple-combination gel was much more evenly applied than the layered ingredients in 100% of cases. 96% of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback